Agonist

Cannabis and derivatives show promise in reducing weight and waist circumference, with nuanced effects on body fat

by
Cannabis and derivatives show promise in reducing weight and waist circumference, with nuanced effects on body fat

In a recent study published in the International Journal of Obesity, researchers examined the effects of cannabis on anthropometric measures. Obesity remains a significant global public health concern, with about 650 million adults affected, per the World Health Organization (WHO). Obesity results in metaphysical changes and chronic conditions that reduce life expectancy. Obesity-related complications are … Read more

Tirzepatide outshines other treatments in lowering blood sugar and weight for type 2 diabetes patients

by
Tirzepatide outshines other treatments in lowering blood sugar and weight for type 2 diabetes patients

In a recent study published in the journal eClinical Medicine, researchers performed a meta-analysis to evaluate the glucose-lowering potential of glucagon-like peptide-1 receptor agonist (GLP-1 RA)-based therapies among diabetes mellitus type 2 (T2D) patients. Novel GLP-1-RAs, including tirzepatide, individually or combined with insulin fixed-ratio combinations (FRCs) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i), as well as high-dosage … Read more

Illustrating the safety of a new drug treatment designed for spinal cord injury

by
Illustrating the safety of a new drug treatment designed for spinal cord injury

New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has demonstrated the safety and tolerability of a new drug treatment designed as a therapeutic intervention for spinal cord injury (SCI). The research, … Read more